课题基金 / 基金详情

SOMATOSTATIN PHYSIOLOGY IN DIABETES AND OBESITY

SOMATOSTATIN PHYSIOLOGY IN DIABETES AND OBESITY
糖尿病和肥胖症中的生长抑素生理学
批准号:
3154585
负责人:
MICHAEL BERELOWITZ
金额:
$11.19万
依托单位国家:
美国
项目类别:
财政年份:
1985
资助国家:
美国
项目状态:
已结题
起止时间:
1985-07-01 至 1987-07-30

项目摘要

项目成果

MICHAEL BERELOWITZ的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Somatostatin (SRIF)-like immunoreactivity (SRIF-LI) is widely distributed through the central nervous system as well as being present in D-cells of the pancreatic islets and gut. SRIF and other peptides with a similar widespread tissue distribution have been identified in unicellular organisms and may be ancient in evolutionay terms. Primeval functions of such peptides may have changed according to local tissue needs with increasing complexity of the organism, as may the mode of delivery (neurotransmission, endocrine or paracrine), while their original overall role may have been retained. In the pancreas and gut SRIF-LI responds to ingested food and circulating nutrients and appears to play a role in the regulation of nutrient homeostasis by influencing both nutrient entry and disposition. The hypothalamus influences nutrient homeostasis through modulation of pituitary hormone secretion, appetite regulation and autonomic nervous control over peripheral glucoregulation. SRIF-LI is present in hypothalamic neurones in areas important in these activities and SRIF influences all three aspects of hypothalamic function. This proposal is based on the hypothesis that SRIF in the hypothalamus, like that in the pancreas and gut, reponds to nutrient stimuli to mediate hypothalamic influences on metabolic control In accordance with this hypothesis hypothalamic lesions that affect metabolic control would alter nutrient regulation of hypothalamic SRIF. Conversely, abnormal peripheral nutrient regulation of hypothalamic SRIF. Conversely, abnormal peripheral nutrient homeostasis woul influence hypothalamic function through disturbances of SRIF regulation. Studies in this proposal are designed to examine this hypothesis by identifying nutrient influences on hypothalamic SRIF-LI secretion and then evaluating disturbances of hypothalamic SRIF-LI regulation (biosynthesis, nuclear content, secretion and molecular heterogeneity) resulting from hypothalamic nuclear lesions or diabetes mellitus.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Glucopenia-mediated release of somatostatin from incubated rat hypothalamus: monosaccharide specificity and role of glycolytic intermediates.
葡萄糖减少症介导的孵化大鼠下丘脑生长抑素的释放:单糖特异性和糖酵解中间体的作用。
DOI: 10.1210/endo-124-2-826
发表时间: 1989
期刊: Endocrinology
影响因子: 4.8
作者: [Berelowitz,M, Ting,NC, Murray,L]
通讯作者: Murray,L
Pituitary insulin-like growth factor-I content and gene expression in the streptozotocin-diabetic rat: evidence for tissue-specific regulation.
链脲佐菌素糖尿病大鼠的垂体胰岛素样生长因子 I 含量和基因表达:组织特异性调节的证据。
DOI: 10.1210/endo-128-2-923
发表时间: 1991
期刊: Endocrinology
影响因子: 4.8
作者: [Olchovsky,D, Bruno,JF, Gelato,MC, Song,J, Berelowitz,M]
通讯作者: Berelowitz,M
GLIPIZIDE-GITS AND METFORMIN ALONE VS COMBINATION THERAPY IN NIDDM
GLIPIZIDE-GITS AND METFORMIN ALONE VS COMBINATION THERAPY IN NIDDM
海外基金